| Effectiveness of mycophenolate mofetil in C3 glomerulonephritis C Rabasco, T Cavero, E Román, J Rojas-Rivera, T Olea, M Espinosa, ... Kidney international 88 (5), 1153-1160, 2015 | 187 | 2015 |
| A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome A Huerta, E Arjona, J Portoles, P Lopez-Sanchez, C Rabasco, ... Kidney international 93 (2), 450-459, 2018 | 150 | 2018 |
| Eculizumab in secondary atypical haemolytic uraemic syndrome T Cavero, C Rabasco, A López, E Román, A Ávila, Á Sevillano, A Huerta, ... Nephrology Dialysis Transplantation 32 (3), 466-474, 2017 | 147 | 2017 |
| Remission of hematuria improves renal survival in IgA nephropathy AM Sevillano, E Gutiérrez, C Yuste, T Cavero, E Mérida, P Rodríguez, ... Journal of the American Society of Nephrology 28 (10), 3089-3099, 2017 | 140 | 2017 |
| Kidney transplant from uncontrolled donation after circulatory death donors maintained by nECMO has long-term outcomes comparable to standard criteria donation after brain death M Molina, F Guerrero-Ramos, M Fernández-Ruiz, E González, J Cabrera, ... American Journal of Transplantation 19 (2), 434-447, 2019 | 57 | 2019 |
| Rituximab for treatment of severe renal disease in ANCA associated vasculitis D Geetha, Z Hruskova, M Segelmark, J Hogan, MD Morgan, T Cavero, ... Journal of nephrology 29, 195-201, 2016 | 50 | 2016 |
| The predictive value of kidney biopsy in renal vasculitis: a multicenter cohort study F Diaz-Crespo, J Villacorta, M Acevedo, T Cavero, C Guerrero, EG Díaz, ... Human pathology 52, 119-127, 2016 | 41 | 2016 |
| Atypical hemolytic uremic syndrome: new challenges in the complement blockage era AI Avila Bernabeu, T Cavero Escribano, M Cao Vilarino Nephron 144 (11), 537-549, 2020 | 38 | 2020 |
| Circulating C3 levels predict renal and global outcome in patients with renal vasculitis J Villacorta, F Diaz-Crespo, M Acevedo, T Cavero, C Guerrero, M Praga, ... Clinical rheumatology 35, 2733-2740, 2016 | 26 | 2016 |
| Malignant hypertension: a type of IgA nephropathy manifestation with poor prognosis ÁM Sevillano, J Cabrera, E Gutiérrez, E Morales, E Mérida, A Huerta, ... Nefrologia 35 (1), 42-49, 2015 | 17 | 2015 |
| Iptacopan, a novel oral complement factor B (FB) inhibitor, significantly reduces proteinuria and C3 deposit scores in native and transplanted kidneys C3 glomerulopathy (C3G … EKS Wong, C Nester, T Cavero Escribano J Am Soc Nephrol 32 (B8), 2021 | 12 | 2021 |
| Where are we with haemolytic uremic syndrome? T Cavero, M Alonso Medicina Clínica (English Edition) 151 (8), 329-335, 2018 | 12 | 2018 |
| Glomerulopatía C3:¿ qué sabemos de esta entidad? T Cavero, M Praga NefroPlus 8, 95-107, 2016 | 11 | 2016 |
| ¿ Cuándo debe sospechar un nefrólogo una enfermedad mitocondrial? T Cavero, C Rabasco, A Molero, A Blázquez, E Hernández, MA Martín, ... Nefrología (Madrid) 35 (1), 6-17, 2015 | 7 | 2015 |
| Nefropatía crónica, hipoacusia neurosensorial y diabetes mellitus T Cavero-Escribano, A Molero-Bermejo, E Ramos-Estévez, ... Nefrología 6 (1), 66-69, 2014 | 5 | 2014 |
| Rechazo agudo del injerto renal no funcionante en pacientes en diálisis después de iniciar tratamiento con interferón y ribavirina T Cavero-Escribano, E Morales-Ruiz, MT Manzano-Peña, ... Nefrología (Madrid) 34 (2), 230-234, 2014 | 5 | 2014 |
| Perigraft fluid collections after kidney transplantation: Does the type of donor (uncontrolled donation after circulatory death vs. donation after brain death) have a role? F Guerrero-Ramos, T Cavero-Escribano, A Rodríguez-Antolín, ... Central European Journal of Urology 70 (4), 439, 2017 | 4 | 2017 |
| Hipertensión arterial maligna: una forma de presentación de la nefropatía IgA con mal pronóstico ÁM Sevillano, J Cabrera, E Gutiérrez, E Morales, E Mérida, A Huerta, ... Nefrología (Madrid) 35 (1), 42-49, 2015 | 4 | 2015 |
| Survival Analysis of Kidney Transplants with Grafts from Uncontrolled DCD Donors under Normothermic Preservation Prior to Organ Retrieval Related to DBD: Data from our 300 … F Guerrero-Ramos, T Cavero-Escribano, A Rodriguez-Antolin, ... Transplantation 102, S408, 2018 | 1 | 2018 |
| # 5163 RATIONAL USE OF ECULIZUMAB IN SECONDARY ATYPICAL HAEMOLYTIC UREMIC SYNDROME LC García-Galán, TC Escribano, E Gutiérrez, JCS Pérez, HT Cuellar, ... Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_5163, 2023 | | 2023 |
